0001004878-19-000105.txt : 20190716
0001004878-19-000105.hdr.sgml : 20190716
20190715192536
ACCESSION NUMBER: 0001004878-19-000105
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190606
ITEM INFORMATION: Entry into a Material Definitive Agreement
FILED AS OF DATE: 20190716
DATE AS OF CHANGE: 20190715
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: United Cannabis Corp
CENTRAL INDEX KEY: 0001436161
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261391338
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54582
FILM NUMBER: 19956028
BUSINESS ADDRESS:
STREET 1: 301 COMMERCIAL RD.
STREET 2: UNIT D
CITY: GOLDEN
STATE: CO
ZIP: 80401
BUSINESS PHONE: 844-278-2420
MAIL ADDRESS:
STREET 1: 301 COMMERCIAL RD.
STREET 2: UNIT D
CITY: GOLDEN
STATE: CO
ZIP: 80401
FORMER COMPANY:
FORMER CONFORMED NAME: MySkin, Inc.
DATE OF NAME CHANGE: 20080528
8-K
1
form8k101cbdagree7-19.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: June 6, 2019
(Date of earliest event reported)
UNITED CANNABIS CORPORATION
-------------------------------------------
(Exact name of registrant as specified in charter)
Colorado
------------------------------------------------
(State or other Jurisdiction of Incorporation
or Organization)
301 Commercial Road, Unit D
000-54582 Golden, CO 80401 46-5221947
-------------------- --------------------------------- -------------------
(Commission File (Address of Principal Executive (IRS Employer
Number) Offices and Zip Code) Identification
Number)
(303) 386-7321
-------------------------------------------
(Registrant's telephone number, including area code)
N/A
----------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-14(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Trading Name of each exchange
each class Symbol(s) on which registered
----------- -------- --------------------
None N/A N/A
Indicate by check mark whether the Registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or
Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).
Emerging Growth Company [ ]
If an emerging growth company, indicate by check mark if the Registrant has
elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13a of the
Exchange Act. [ ]
Item 1.01. Entry Into A Material Definitive Agreement.
On June 6, 2019, United Cannabis Corporation (the "Company") signed an
agreement to supply CBD isolate over the next 100 weeks to an unrelated third
party.
The Agreement provides that the purchase price for the CBD isolate may be
adjusted by the mutual agreement of the parties. If either party requests a
price adjustment in advance of the next week's purchase, and the other party
does not agree to the adjustment, then the order for that week only will be
cancelled.
If the third party completes the purchase of the CBD isolate, the Company
estimates that this contract will produce revenues over the next two years of
approximately $42,000,000 for the Company.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
UNITED CANNABIS CORPORATION
Dated: July 15, 2019 By: /s/ John Walsh
-------------------------------
John Walsh
Chief Financial Officer
3